NASDAQ:GERN GERON CORP
Geron was kneecapped by the FDA hold 4 months ago. The Mayo Clinic had a partial hold also levied on their research. Recently the FDA released the partial hold on the Mayo, and it is assumed GERN will use the same data to sway the FDA into releasing their hold. Also there will be a 1 for 24 share divi for GERN HOLDERS of record of May 28th in a new company Asterias --AST. This will take place before the end of July and should add some notice by the investment community. Mayo Clinic has been VERY on Geron's Imetelstat drug for treating blood cancers and expect to see more data on their trials in the not too distant future. I think the squeezed BBs with indications from both the Stochastics and are indicating a high probability of a short term to intermediate term upwards move.